You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aged (at least 18 years old)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemophilia B Trial (BBM-H901)

Not yet recruiting
  • Hemophilia B
  • (no location specified)
Feb 6, 2023

Hepatitis A Trial (Healive (hepatitis A vacine(human diploid cell), inactivated))

Not yet recruiting
  • Hepatitis A
  • Healive (hepatitis A vacine(human diploid cell), inactivated)
  • (no location specified)
Sep 21, 2023

COVID-19 Trial in Nanjing (One dose group, Two doses group, Aged 18-59 years)

Not yet recruiting
  • COVID-19
  • One dose group
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Dec 25, 2022

COVID-19 Pneumonia, COVID-19 Trial in Abu Dhabi (SARS-CoV-2 Vaccine (Vero Cell), Inactivated)

Recruiting
  • COVID-19 Pneumonia
  • COVID-19
  • SARS-CoV-2 Vaccine (Vero Cell), Inactivated
  • Abu Dhabi, United Arab Emirates
    Sheikh Khalifa Medical City, SEHA
Jul 10, 2022

Covid19 Trial in Xinxiang (3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated, 3-doses schedule 2 of COVID-19

Recruiting
  • Covid19
  • 3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated
  • +3 more
  • Xinxiang, Henan, China
    Yanjin County Center for Disease Control and Prevention
Jun 15, 2022

Elderly Volunteers Trial in Paris (Biological samples collection (blood + feces))

Recruiting
  • Elderly Volunteers
  • Biological samples collection (blood + feces)
  • Paris, France
    Biofortis
Jul 24, 2023

Chronic GVHD Trial (Belumosudil)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • (no location specified)
Jan 5, 2023

COVID-19 Trial in Changde, Changning, Zhuzhou (Omicron COVID-19 Vaccine (Vero Cell), Inactivated, COVID-19 Vaccine (Vero Cell),

Recruiting
  • COVID-19
  • Omicron COVID-19 Vaccine (Vero Cell), Inactivated
  • COVID-19 Vaccine (Vero Cell), Inactivated
  • Changde, Hunan, China
  • +2 more
May 30, 2022

Cervical Cancer, Condylomata Acuminata Trial in Chengdu (3 doses of the Recombinant Human Papillomavirus Nonavalent (Types

Active, not recruiting
  • Cervical Cancer
  • Condylomata Acuminata
  • 3 doses of the Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
  • 2 doses of theRecombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
  • Chengdu, Sichuan, China
    Sichuan Provincial Centre for Disease Control and Prevention
Oct 2, 2021

Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (VAC?6 vaccine - ?nce at a dose of 106 PFU, VAC?6 vaccine - once at a dose of

Completed
  • Smallpox
  • +3 more
  • VAC∆6 vaccine - оnce at a dose of 10⁶ PFU
  • +3 more
  • Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
    Federal State Budgetary Healthcare Institution - Medical and San
Feb 28, 2023

COVID-19 Trial in Tongren (Experimental vaccine 1, Experimental vaccine 2, Experimental vaccine 3)

Suspended
  • COVID-19
  • Experimental vaccine 1
  • +2 more
  • Tongren, Guizhou, China
    Yanhe Tujia Autonomous County Center for Disease Control and Pre
Aug 9, 2022

COVID-19 Trial in Nanjing (a middle-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56,

Recruiting
  • COVID-19
  • a middle-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56
  • +7 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Diseases Control and Prevention
Mar 28, 2022

Influenza Trial in Ghent (OVX836, Quadrivalent seasonal influenza vaccine (Influvac TetraTM))

Completed
  • Influenza
  • OVX836
  • Quadrivalent seasonal influenza vaccine (Influvac TetraTM)
  • Ghent, Belgium
    Centre for Vaccinology (CEVAC)
Sep 20, 2022

SARS-CoV-2 Trial in Australia, Philippines, United States (CV0501 (3 µg), CV0501 (6 µg), CV0501 (12 µg))

Not yet recruiting
  • SARS-CoV-2
  • CV0501 (3 μg)
  • +8 more
  • Sacramento, California
  • +19 more
Jul 27, 2022

Irritable Bowel Syndrome Trial in Fayetteville (MHNA-001)

Active, not recruiting
  • Irritable Bowel Syndrome
  • MHNA-001
  • Fayetteville, North Carolina
    Carolina Institute for Clinical Research
Jan 23, 2023

COVID-19 Trial in Worldwide (Inactivated SARS-CoV-2 Vaccine (Vero cell), Placebo)

Recruiting
  • COVID-19
  • Inactivated SARS-CoV-2 Vaccine (Vero cell)
  • Placebo
  • Sanabis, Bahrain
  • +5 more
Jan 22, 2022

Glycogen Storage Disease Type II Infantile Onset Trial in Gainesville (Cipaglucosidase alfa (ATB200), Miglustat (AT2221))

Recruiting
  • Glycogen Storage Disease Type II Infantile Onset
  • Gainesville, Florida
    University of Florida Clinical Research Center
Jan 18, 2023

COVID-19 Trial in United States (Nirmatrelvir, Ritonavir, Placebo for nirmatrelvir)

Not yet recruiting
  • COVID-19
  • Miami, Florida
  • +2 more
Jul 21, 2022

Asthma Trial (Mometasone Furoate)

Terminated
Has Results
  • Asthma
  • Mometasone Furoate
  • (no location specified)
Feb 7, 2022

Asthma in Children Trial in Rochester (AsthmaTuner, Asthma-Guidance and Prediction System)

Not yet recruiting
  • Asthma in Children
  • AsthmaTuner
  • Asthma-Guidance and Prediction System
  • Rochester, Minnesota
    Mayo Clinic
Sep 25, 2023

Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Trial in United Kingdom, United States (Cannabidiol Oral Solution

Not yet recruiting
  • Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
  • Cannabidiol Oral Solution [Epidiolex]
  • Los Angeles, California
  • +6 more
May 9, 2023

Cervical Intraepithelial Neoplasia, Cervical Cancer, Vaginal Intraepithelial Neoplasia Trial in Dongtai (Recombinant Human

Completed
  • Cervical Intraepithelial Neoplasia
  • +4 more
  • Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) / Cecolin®
  • Dongtai, Jiangsu, China
    Dongtai City Center for Disease Control and Prevention Dongtai,
Jun 22, 2022

Rotavirus Infections, Rotavirus Vaccines Trial in Perm (The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried),

Completed
  • Rotavirus Infections
  • Rotavirus Vaccines
  • The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried)
  • Placebo
  • Perm, Russian Federation
    Perm State Medical University named after Academician E.A. Wagne
Aug 31, 2021

COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant

Not yet recruiting
  • COVID-19
  • High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
  • +3 more
  • (no location specified)
Jun 19, 2023

Acute Respiratory Viral Infection Trial in Russian Federation (Raphamin, Placebo)

Recruiting
  • Acute Respiratory Viral Infection
  • Ekaterinburg, Russian Federation
  • +30 more
Jan 20, 2023